165 related articles for article (PubMed ID: 9742556)
1. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide.
Fathy M; Safwat SM; el-Shanawany SM; Shawky Tous S; Otagiri M
Pharm Dev Technol; 1998 Aug; 3(3):355-64. PubMed ID: 9742556
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.
Imai T; Kawasaki C; Nishiyama T; Otagiri M
Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544
[TBL] [Abstract][Full Text] [Related]
3. Release behaviour of diclofenac sodium dispersed in Gelucire and encapsulated with alginate beads.
Al-Taani B; Khanfar MS; Salem MS; Sallam A
J Microencapsul; 2010; 27(1):10-3. PubMed ID: 20078392
[TBL] [Abstract][Full Text] [Related]
4. Development of polysaccharide gel-coated pellets for oral administration. 2. Calcium alginate.
Sriamornsak P; Kennedy RA
Eur J Pharm Sci; 2006 Oct; 29(2):139-47. PubMed ID: 16919918
[TBL] [Abstract][Full Text] [Related]
5. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
El-Kamel AH; Al-Gohary OM; Hosny EA
J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
[TBL] [Abstract][Full Text] [Related]
6. Modulation of drug release from glyceryl palmitostearate-alginate beads via heat treatment.
Pongjanyakul T; Sungthongjeen S; Puttipipatkhachorn S
Int J Pharm; 2006 Aug; 319(1-2):20-8. PubMed ID: 16677785
[TBL] [Abstract][Full Text] [Related]
7. Xanthan-alginate composite gel beads: molecular interaction and in vitro characterization.
Pongjanyakul T; Puttipipatkhachorn S
Int J Pharm; 2007 Feb; 331(1):61-71. PubMed ID: 17046185
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal.
Mandal B; Alexander KS; Riga AT
Pharmazie; 2010 Feb; 65(2):106-9. PubMed ID: 20225653
[TBL] [Abstract][Full Text] [Related]
9. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
[TBL] [Abstract][Full Text] [Related]
10. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
11. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials.
Kim MS; Park GD; Jun SW; Lee S; Park JS; Hwang SJ
J Pharm Pharmacol; 2005 Dec; 57(12):1521-8. PubMed ID: 16354396
[TBL] [Abstract][Full Text] [Related]
12. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
13. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.
Lin YH; Liang HF; Chung CK; Chen MC; Sung HW
Biomaterials; 2005 May; 26(14):2105-13. PubMed ID: 15576185
[TBL] [Abstract][Full Text] [Related]
14. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads.
Pasparakis G; Bouropoulos N
Int J Pharm; 2006 Oct; 323(1-2):34-42. PubMed ID: 16828245
[TBL] [Abstract][Full Text] [Related]
15. A combined technique based on prilling and microwave assisted treatments for the production of ketoprofen controlled release dosage forms.
Auriemma G; Del Gaudio P; Barba AA; d'Amore M; Aquino RP
Int J Pharm; 2011 Aug; 415(1-2):196-205. PubMed ID: 21679754
[TBL] [Abstract][Full Text] [Related]
16. Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds.
Mandal BB; Kundu SC
Biomaterials; 2009 Oct; 30(28):5170-7. PubMed ID: 19552952
[TBL] [Abstract][Full Text] [Related]
17. Adipic acid dihydrazide treated partially oxidized alginate beads for sustained oral delivery of flurbiprofen.
Maiti S; Singha K; Ray S; Dey P; Sa B
Pharm Dev Technol; 2009; 14(5):461-70. PubMed ID: 19235554
[TBL] [Abstract][Full Text] [Related]
18. Floating dosage forms to prolong gastro-retention--the characterisation of calcium alginate beads.
Stops F; Fell JT; Collett JH; Martini LG
Int J Pharm; 2008 Feb; 350(1-2):301-11. PubMed ID: 17964096
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of sustained release calcium alginate beads and matrix tablets of acetazolamide.
Barzegar-Jalali M; Hanaee J; Omidi Y; Ghanbarzadeh S; Ziaee S; Bairami-Atashgah R; Adibkia K
Drug Res (Stuttg); 2013 Feb; 63(2):60-4. PubMed ID: 23447074
[TBL] [Abstract][Full Text] [Related]
20. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex.
Halder A; Maiti S; Sa B
Int J Pharm; 2005 Sep; 302(1-2):84-94. PubMed ID: 16102927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
